沙丁胺醇、异丙托溴胺联合雾化吸入治疗支气管哮喘效果分析

The Effect of Inhalation of Salbutamol and Ipratropium Bromide in the Treatment of Bronchial Asthma

目的分析沙丁胺醇、异丙托溴胺联合雾化吸入治疗支气管哮喘效果。方法选取2015年2月10日—2017年2月11日我院收治的支气管哮喘患者共50例作为研究对象。将支气管哮喘患者(50例)随机分为观察组、对照组,观察组(25例)患者-实施沙丁胺醇、异丙托溴胺联合雾化吸入治疗,对照组(25例)患者-实施常规治疗。结果观察组支气管哮喘患者的咳嗽缓解时间(2.15±0.24)d,住院时间(10.15±2.11)d,胸闷缓解时间(3.25±0.11)d,优于对照组,差异具有统计学意义(P<0.05)。结论通过对支气管哮喘患者实施沙丁胺醇、异丙托溴胺联合雾化吸入治疗,能改善患者临床症状,缩短患者住院时间,促进患者康复。

Objective To analyze the effect of inhalation of salbutamol and ipratropium bromide in the treatment of bronchial asthma. Methods A total of 50 patients with bronchial asthma treated in our hospital from February 10, 2015 to February 11, 2017 were selected as the research subjects. The patients with bronchial asthma （50 cases） were randomly divided into the observation group and the control group. The observation group （25 cases） was treated with inhalation of salbutamol and ipratropium bromide combined with inhalation. The control group （25 cases） was treated with routine treatment. Results The cough relief time （2.15±0.24） d, hospitalization time （10.15±2.11） d and chest pain relief time （3.25±0.11） d in the observation group, were signifcantly better than those in the control group, the difference was statistically significant （P 〈 0.05）. Conclusion The inhalation of salbutamol and ipratropium bromide combined with aerosol inhalation can improve clinical symptoms, shorten hospitalization time and promote recovery of patients.